Clinical Trials on Age 50 - 74 for Females or 60-74 for Males in France
Total 86 results
-
Galderma R&DCompletedHealthy Subjects, Male or Female, of 18-60 Years Old, With Phototype I, II or III, Not Pre-treated/Pre-protected SkinFrance
-
University Hospital, MontpellierCompleted
-
Hospices Civils de LyonCompletedBladder ExstrophyFrance
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria | PH1 | RNAi Therapeutic | siRNA | AGTFrance, United Kingdom, Netherlands, Israel, Germany
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University Hospital, MontpellierRecruitingSearch for Structural Variants in Patients With DSD and Inconclusive Molecular Diagnosis (GENEXPLOR)Disorder of Sex Development, 46,XYFrance
-
Hospices Civils de LyonCompletedMedullary Sponge KidneyFrance
-
Hospices Civils de LyonActive, not recruiting
-
Institut National de la Santé Et de la Recherche...Recruiting
-
Soutien aux Actions contre les Maladies du Globule...NovartisCompletedChange in Albumin to Creatinine Ratio and Glomerular Filtration Rate | Progression of Kidney Failure and or All-cause MortalityFrance
-
Hospices Civils de LyonRecruitingPatients With PH1 Treated With Lumasiran in FranceFrance
-
Centre Hospitalier Universitaire de NiceCompletedEnd-stage Renal DiseaseFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMulti-organ Failure After Severe TraumaFrance
-
Klinikum NürnbergRecruitingChronic Renal Failure | Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte HomeostatisGermany, France
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Hospices Civils de LyonCompletedClassic Congenital Adrenal HyperplasiaFrance
-
Central Hospital, Nancy, FranceCompletedTurner SyndromeFrance
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 (PH1) | Primary HyperoxaluriaUnited States, France, United Kingdom, Israel, Germany
-
University Hospital, Strasbourg, FranceRecruiting
-
Centre Oscar LambretRecruiting
-
University Medical Center GroningenNot yet recruitingADPKDNetherlands, United Kingdom, Belgium, Germany, France, Spain
-
Assistance Publique - Hôpitaux de ParisCompletedNephroblastoma With Vena Cava ThrombosisFrance
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Italy, France, Lebanon, Belgium, Netherlands, Israel, United Arab Emirates, Australia, Jordan, Turkey
-
Hospices Civils de LyonRecruiting
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruitingAtezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours (SABR-PDL1)Patients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma )France
-
ADDMEDICA SASARecruitingSickle Cell DiseaseFrance, Côte D'Ivoire, Guadeloupe, Mali, Martinique, Senegal
-
University Hospital, MontpellierRecruiting
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria Type 1 (PH1)United States, France, United Kingdom, Switzerland, Netherlands, Israel, Germany, United Arab Emirates
-
Enyo PharmaNot yet recruitingAlport SyndromeSpain, United States, France, Germany
-
Alnylam PharmaceuticalsRecruitingPrimary Hyperoxaluria Type 1France, Spain, United States, Israel, Belgium, Switzerland, Germany, United Kingdom, Italy, Canada
-
Urovant Sciences GmbHRecruitingNeurogenic Detrusor OveractivityUnited States
-
IpsenActive, not recruitingLocally Advanced or Metastatic Renal Cell CarcinomaSpain, France, United Kingdom, Switzerland, Germany, Netherlands, Austria
-
European Organisation for Research and Treatment...PfizerCompletedLocally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma | Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor | Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 | Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma | Locally Advanced... and other conditionsFrance, Belgium, Netherlands, Germany, United Kingdom, Italy, Norway, Poland, Slovakia, Slovenia
-
Novartis PharmaceuticalsActive, not recruitingCarcinoma, Renal CellSpain, Singapore, Czechia, Italy, Japan, France, United States
-
Genzyme, a Sanofi CompanyTerminatedAlport SyndromeAustralia, United States, China, France, Germany, Spain, United Kingdom
-
Adlai Nortye Biopharma Co., Ltd.Merck Sharp & Dohme LLCActive, not recruitingCervical Cancer | Triple-negative Breast Cancer | NSCLC, Squamous or Non-Squamous | Urothelial Carcinoma of the Bladder | Microsatellite Stable (MSS) Colorectal Cancer (CRC)United States, France
-
Kyowa Kirin Pharmaceutical Development LtdCompletedX-linked Hypophosphatemia (XLH)Sweden, Spain, United Kingdom, Italy, Austria, France
-
River 3 Renal Corp.RecruitingFocal Segmental Glomerulosclerosis | Alport SyndromeUnited States, Belgium, United Kingdom, France, Germany, Netherlands
-
Diurnal LimitedEnrolling by invitationCongenital Adrenal HyperplasiaUnited States, France, Japan
-
Diurnal LimitedCompletedCongenital Adrenal HyperplasiaFrance, United States, Japan
-
Reata, a wholly owned subsidiary of BiogenCompletedAlport SyndromeUnited States, United Kingdom, Japan, Australia, France, Germany, Puerto Rico, Spain
-
Laminate Medical TechnologiesCompletedKidney Diseases | Kidney Failure, Chronic | ESRD | Renal Failure Chronic | Arterio-Venous Fistula | Arteriovenous Fistula ThrombosisUnited Kingdom, Spain, Germany, France
-
Centre d'Etude des Cellules SouchesGenethonRecruitingWolfram SyndromeFrance, Spain
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAutosomal Recessive Polycystic Kidney (ARPKD)United States, United Kingdom, Belgium, Poland, France, Germany, Italy
-
Kyowa Kirin, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaNetherlands, United States, United Kingdom, France
-
Ferring PharmaceuticalsCompletedTurner's Syndrome | Human Growth Hormone DeficiencyFrance
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingEnd Stage Renal Disease | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1Germany, Spain, United States, United Kingdom, Italy, United Arab Emirates, Lebanon, Morocco, France, Romania
-
Novo Nordisk A/SCompletedKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)Poland, United States, United Kingdom, New Zealand, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain